New grad roles at Mineralys Therapeutics, Inc.
Mineralys Therapeutics is a publicly traded, clinical-stage biopharmaceutical company developing lorundrostat, a selective aldosterone synthase inhibitor for hypertension, chronic kidney disease, and related cardio-renal-metabolic diseases driven by dysregulated aldosterone.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Public
- Open roles
- 8
No current roles
Clear a filter to see every role.
Get new Mineralys Therapeutics, Inc. new grad roles by email
Free account. Get new Mineralys Therapeutics, Inc. new grad roles by email or push the minute they post.
